TOG Review (RCOG Journal)

MRCOG Part 2

Maternal Medicine

Management of adnexal masses in pregnancy

Key Statistics

  • 0.19–8.8% — Prevalence of adnexal mass in pregnancy
  • 1:1500–32,000 — Incidence of ovarian malignancy
  • 76% — Are simple cysts <5 CM

Don't-miss facts

  1. Do not operate before 14–16 weeks unless acute — removing the corpus luteum may cause miscarriage

  2. Surgery indicated: acute abdomen · suspicious mass · growth >20% · cyst >10 cm (labour obstruction)

  3. Torsion: 1–5/10,000 pregnancies, 16% with OHSS — operate immediately; presence of ovarian Doppler flow does not exclude it

  4. CA125 raised by decidua (peak 1st trimester); suggested cut-off 112 U/ml at 11–14 weeks. LDH unaffected by pregnancy

  5. Any IOTA M rule → refer to gynaecological oncology MDT (IOTA sensitivity 95%, specificity 91%)

  6. Dermoid >6 cm: torsion risk ~27%; dermoids are the commonest cystic lesion after 16 weeks

  7. Laparoscopy safe at 12–15 mmHg; use Hasson/Palmer’s entry; laparotomy if malignancy suspected (port-site metastases, spillage)

  8. Doxycycline contraindicated >15 weeks for PID; OHSS — do not drain, operate only for torsion/rupture

Ultrasound buzzwords

Ring of fire – corpus luteal cyst Spoke wheel – hyperstimulated ovaries White ball (hair/sebum) – dermoid

Ground glass – endometrioma Beads-on-a-string – hydrosalpinx Whirlpool sign – torsion

Crescent sign – excludes invasive cancer, not LMP

Malignant ultrasound features

Solid components Papillary projections >6 mm High colour score in projections Growth >20% between scans

Septations Free fluid beyond pouch of Douglas

Abbreviation Key

  • LMP — low malignant potential (borderline)
  • LDH — lactate dehydrogenase
  • OHSS — ovarian hyperstimulation syndrome
  • hCG — human chorionic gonadotrophin
  • IOTA — International Ovarian Tumour Analysis
  • MDT — multidisciplinary team
  • RMI — risk of malignancy index
  • FNA — fine needle aspiration
  • ROMA — Risk of Ovarian Malignancy Algorithm
  • FIGO — International Federation of Gynecology and Obstetrics
  • HE4 — human epididymis protein 4
  • PID — pelvic inflammatory disease

Source: Alalade AO, Maraj H. Management of adnexal masses in pregnancy. The Obstetrician & Gynaecologist 2017;19:317–325. doi:10.1111/tog.12417

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free